4-Amino-6-chloropyrimidine-5-carbonitrile (cas: 60025-09-4) belongs to nitriles. Nitrile compounds can be prepared by the incorporation of a cyanide source through C–C bond formation or by dehydration of primary carboxamides. Nitrile groups in organic compounds can undergo a variety of reactions depending on the reactants or conditions. A nitrile group can be hydrolyzed, reduced, or ejected from a molecule as a cyanide ion.Application of 60025-09-4
Discovery of a Potent and Selective PI3Kδ Inhibitor (S)-2,4-Diamino-6-((1-(7-fluoro-1-(4-fluorophenyl)-4-oxo-3-phenyl-4H-quinolizin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile with Improved Pharmacokinetic Profile and Superior Efficacy in Hematological Cancer Models was written by Shukla, Manojkumar R.;Patra, Sukanya;Verma, Mahip;Sadasivam, Gayathri;Jana, Nirmal;Mahangare, Sachin J.;Vidhate, Prashant;Lagad, Dipak;Tarage, Anand;Cheemala, Murthy;Kulkarni, Chaitanya;Bhagwat, Shankar;Chaudhari, Vinod D.;Sayyed, Majid;Pachpute, Vipul;Phadtare, Ramesh;Gole, Gopal;Phukan, Samiron;Sunkara, Brahmam;Samant, Charudatt;Shingare, Manisha;Naik, Aditya;Trivedi, Sneha;Marisetti, Ajit Kumar;Reddy, Madhusudhan;Gholve, Milind;Mahajan, Nilesh;Sabde, Sudeep;Patil, Vinod;Modi, Dipak;Mehta, Maneesh;Nigade, Prashant;Tamane, Kaustubh;Tota, Swati;Goyal, Hemant;Volam, Harish;Pawar, Shashikant;Ahirrao, Prajakta;Dinchhana, Lal;Mallurwar, Sadanand;Akarte, Atul;Bokare, Anand;Kanhere, Rupesh;Reddy, Neetinkumar;Koul, Sarita;Dandekar, Manoj;Singh, Minakshi;Bernstein, Peter R.;Narasimham, Lakshmi;Bhonde, Mandar;Gundu, Jayasagar;Goel, Rajan;Kulkarni, Sanjeev;Sharma, Sharad;Kamboj, Rajender Kumar;Palle, Venkata P.. And the article was included in Journal of Medicinal Chemistry in 2020.Application of 60025-09-4 This article mentions the following:
PI3Kδ inhibitors have been approved for B-cell malignancies like CLL, small lymphocytic lymphoma, and so forth. However, currently available PI3Kδ inhibitors are nonoptimal, showing weakness against at least one of the several important properties: potency, isoform selectivity, and/or pharmacokinetic profile. To come up with a PI3Kδ inhibitor that overcomes all these deficiencies, a pharmacophoric expansion strategy was employed. Herein, we describe a systematic transformation of a “three-blade propeller” shaped lead, 2,3-disubstituted quinolizinone 11, through a 1,2-disubstituted quinolizinone 20 to a novel “four-blade propeller” shaped 1,2,3-trisubstituted quinolizinone 34. Compound 34 (I)has excellent potency, isoform selectivity, metabolic stability across species, and exhibited a favorable pharmacokinetic profile. Compound 34 also demonstrated a differentiated efficacy profile in human germinal center B and activated B cell-DLBCL cell lines and xenograft models. Compound 34 qualifies for further evaluation as a candidate for monotherapy or in combination with other targeted agents in DLBCLs and other forms of iNHL. In the experiment, the researchers used many compounds, for example, 4-Amino-6-chloropyrimidine-5-carbonitrile (cas: 60025-09-4Application of 60025-09-4).
4-Amino-6-chloropyrimidine-5-carbonitrile (cas: 60025-09-4) belongs to nitriles. Nitrile compounds can be prepared by the incorporation of a cyanide source through C–C bond formation or by dehydration of primary carboxamides. Nitrile groups in organic compounds can undergo a variety of reactions depending on the reactants or conditions. A nitrile group can be hydrolyzed, reduced, or ejected from a molecule as a cyanide ion.Application of 60025-09-4
Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts